About CPRI:
CPRI is an R&D based enterprise specialized in R&D and manufacturing of hard-to-find generic API as well as advanced intermediates.
History: Founded in 1950s, previously well known as the state-run Chongqing Pharmaceutical Research Institute, CPRI was one of the pioneers involved in drug R&D and cGMP-compliant API manufa- cturing in China. In 1994, generic API of Clindamycin HCl we’d developed was approved by US FDA. Now, CPRI is a subsidiary of FOSUN Pharmaceutical (Group), Co., Ltd, which is a leading pharmaceutical company in China.
Faculty and Facility: R&D and quality management are well supported with the latest method of pharmaceutical analysis and the most advanced equipment including GC, LC/MS, HPLCs, UV...
Read more
Read more
Feature Products
Company Profile
Basic Information
| Company Name: | Chongqing Pharmaceutical Research Institute Co., Ltd |
|---|---|
| Business Type: | Manufacture |
| Product/Service: | APIs advanced intermediates pemetrexed |
| Number of Employees: | 51 ~ 200 people |
Trade & Market
| Main Markets: |
Worldwide |
|---|---|
| Industry: | Chemicals |
| AnnualTurnover: | 2.5 ~ 5 Million US$ |
Other Information
| Year Established: | 1969 |
|---|---|
| Legal Representative / CEO: | Li weijing |
| ShowRoom: | http://www.tradevv.com/chinasupliers/cpri8623 |
Didn't find what you're looking for?
Post a buying lead.
Contact Us
Chongqing Pharmaceutical Research Institute Co., Ltd
[China]
City : Chongqing
Province/State : Chongqing
Country/Region : China
